ZHENG Shu, HUANG Ling. Determination of TP53 Mutation for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage Ⅲ Colon Cancer Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 267-269. DOI: 10.3969/j.issn.1671-5144.2006.05.004
|
Citation:
|
ZHENG Shu, HUANG Ling. Determination of TP53 Mutation for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage Ⅲ Colon Cancer Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 267-269. DOI: 10.3969/j.issn.1671-5144.2006.05.004
|
ZHENG Shu, HUANG Ling. Determination of TP53 Mutation for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage Ⅲ Colon Cancer Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 267-269. DOI: 10.3969/j.issn.1671-5144.2006.05.004
|
Citation:
|
ZHENG Shu, HUANG Ling. Determination of TP53 Mutation for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage Ⅲ Colon Cancer Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(5): 267-269. DOI: 10.3969/j.issn.1671-5144.2006.05.004
|
DownLoad: